Silvia I Vanzulli Selected Research

Silvia I Vanzulli Research Topics

Disease

14	Neoplasms (Cancer) 01/2021 - 01/2002
10	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2005
8	Carcinoma (Carcinomatosis) 01/2019 - 01/2005
3	Adenocarcinoma 08/2018 - 01/2002
2	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2005
1	Melanoma (Melanoma, Malignant) 06/2019
1	Necrosis 06/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Inflammation (Inflammations) 05/2015
1	Infections 09/2011
1	Arthritis (Polyarthritis) 09/2011
1	Hypoxia (Hypoxemia) 11/2010
1	Carcinogenesis 01/2007
1	Hemorrhage 10/2005
1	Body Weight (Weight, Body) 01/2005
1	Fibrosarcoma 01/2002
1	Lymphoid Leukemia 01/2002
1	Teratoma (Teratoid Tumor) 01/2002

Drug/Important Bio-Agent (IBA)

8	Hormones (Hormone)IBA 01/2021 - 01/2002
8	Progesterone Receptors (Progesterone Receptor)IBA 05/2014 - 01/2005
6	Progestins (Progestagens)IBA 06/2012 - 01/2005
5	Estrogen ReceptorsIBA 01/2019 - 01/2002
5	Estrogen Receptor alphaIBA 01/2019 - 01/2005
3	Mifepristone (RU 486)FDA Link 01/2021 - 01/2005
3	Progesterone FDA LinkGeneric 05/2012 - 01/2002
3	Estrogens (Estrogen)FDA Link 06/2010 - 01/2002
2	Phenobarbital (Luminal)FDA Link 01/2019 - 06/2012
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 06/2012 - 05/2011
2	Fulvestrant (Faslodex)FDA Link 05/2012 - 01/2012
2	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2012 - 01/2007
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2011 - 06/2010
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	Melanins (Melanin)IBA 06/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	Androgen Antagonists (Antiandrogens)IBA 01/2019
1	LigandsIBA 01/2019
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019
1	Antimicrobial PeptidesIBA 05/2015
1	Protein Isoforms (Isoforms)IBA 05/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2014
1	Pharmaceutical PreparationsIBA 05/2014
1	Albumin-Bound Paclitaxel FDA Link 05/2014
1	130-nm albumin-bound paclitaxelIBA 05/2014
1	Therapeutic UsesIBA 05/2014
1	Liposomes (Liposome)IBA 05/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	Cyclin D1IBA 05/2012
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2012
1	Steroid Receptors (Steroid Receptor)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 09/2011
1	Matrix Metalloproteinases (MMPs)IBA 09/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2011
1	ChemokinesIBA 09/2011
1	CollagenIBA 09/2011
1	CytokinesIBA 09/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2011
1	DNA (Deoxyribonucleic Acid)IBA 05/2011
1	SteroidsIBA 05/2011
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 05/2011
1	Conditioned Culture MediaIBA 11/2010
1	cobaltous chloride (cobalt(II)chloride)IBA 11/2010
1	progesterone receptor AIBA 01/2007
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2005
1	SolutionsIBA 10/2005
1	porphine (porphin)IBA 10/2005
1	Glycerol (Glycerine)FDA LinkGeneric 10/2005
1	Oxygen (Dioxygen)IBA 10/2005
1	Photosensitizing Agents (Photosensitizers)IBA 10/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2005
1	tetra(4-N-methylpyridyl)porphineIBA 10/2005
1	PorphyrinsIBA 10/2005
1	Saline SolutionIBA 10/2005
1	Bromodeoxyuridine (BrdU)IBA 01/2005
1	Antisense OligonucleotidesIBA 01/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2005
1	OligodeoxyribonucleotidesIBA 01/2005
1	MedroxyprogesteroneIBA 01/2002
1	MethylcholanthreneIBA 01/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 06/2005
2	Photothermal Therapy 06/2019 - 08/2018
2	Lasers (Laser) 06/2019 - 08/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 05/2014
1	Immunotherapy 01/2021
1	Contraception (Birth Control) 05/2012
1	Photochemotherapy (Photodynamic Therapy) 10/2005